Section: Press - posted in 2018

  • Inform Diagnostics GI Pathologists Recognized by AACC for Outstanding Research Abstract

    IRVING, Texas, July 31, 2018 — A research abstract authored by pathologists at Inform Diagnostics has been awarded “Outstanding Abstract” in the 2018 Therapeutic Drug Management and Toxicology Division Abstract Competition conducted by the American Association for Clinical Chemistry (AACC). Titled “ Therapeutic Drug Monitoring of Monoclonal Antibody in Inflammatory Bowel ...
    Continue Reading
  • Inform Diagnostics GI Pathologists Will Present Four Posters at the AGA’s Digestive Disease Week

    Inform Diagnostics GI Pathologists Will Present Four Posters at the AGA’s Digestive Disease Week IRVING, Texas, May 23, 2018 — Four research posters from GI pathologists at Inform Diagnostics have been accepted for the American Gastroenterological Association’s annual meeting, Digestive Disease Week. The conference will be held June 2–5 in Washington, D.C. “Gastric ...
    Continue Reading
  • GI Pathologists at Inform Diagnostics Publish Noteworthy Articles in Major Journals

    IRVING, Texas, May 14, 2018 — GI pathologists at Inform Diagnostics continue to publish noteworthy articles in respected peer-reviewed medical journals. One recent article challenges current clinical assumptions about gastrointestinal polyps. Published in American Journal of Gastroenterology, “Lesions of All Types Exist in Colon Polyps of All Sizes” reports the stratification of ...
    Continue Reading
  • Miraca Life Sciences Announces Company Name Change to Inform Diagnostics

    IRVING, Texas, January 8, 2018 — Inform Diagnostics Life Sciences announced today that it has changed its name to Inform Diagnostics effective immediately. The company was acquired in November by Avista Capital Partners from previous owner Miraca Holdings. The name Inform Diagnostics and new logo were chosen to highlight the company’s focus on providing pathology and diagnostic ...
    Continue Reading